Conneqt Health Limited has released a press release.
Study Finds Central Aortic Waveform Improves HF Treatment
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Conneqt Health
- Tax refund
- Positive Novartis drug trial using SphygmoCor XCEL
- AtCor completes share placement
- Leading research team highlights role of SphygmoCor
- FY2016 results
Later from Conneqt Health
- AtCor Signs Local Health System Agreement
- Business update and Strategic Review
- AtCor Signs New Network Health Systems Agreement
- Secures $0.8 million new pharmaceutical trials contracts
- AtCor Signs New Agreement
Follow Conneqt Health into a list and get an email when it puts out news.
Follow Conneqt Health